Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
4.530
+0.040 (0.89%)
Oct 31, 2025, 12:45 PM EDT - Market open
Cryo-Cell International Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Cryo-Cell International in the last 12 months.
Price Target: n/a
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Cryo-Cell International is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 20, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $9 → $8.5 | Strong Buy | Maintains | $9 → $8.5 | +87.64% | Mar 4, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +164.90% | Aug 29, 2022 |
Financial Forecast
Revenue This Year
32.55M
from 31.99M
Increased by 1.75%
Revenue Next Year
32.53M
from 32.55M
Decreased by -0.05%
EPS This Year
n/a
from 0.05
EPS Next Year
-0.11
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 33.5M | 33.5M |
| Avg | 32.5M | 32.5M |
| Low | 31.3M | 31.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 4.7% | 2.9% |
| Avg | 1.8% | -0.0% |
| Low | -2.2% | -4.0% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | - | -0.12 |
| Avg | - | -0.11 |
| Low | - | -0.11 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.